LONG-TERM OUTCOMES OF STEROID WITHDRAWAL BETWEEN 3 AND 6 MONTHS AFTER KIDNEY TRANSPLANTATION WITH INDUCTION THERAPY AND TACROLIMUS AND MYCOPHENOLATE MOFETIL

被引：0
|
作者：
Hwang, Subin [1 ]
Kim, Jinhae [1 ]
Park, Jeeeun [1 ]
Jang, Hye Ryoun [1 ]
Lee, Jung Eun [1 ]
Kim, Yoon-Goo [1 ]
Kim, Dae Joong [1 ]
Oh, Ha Young [1 ]
Huh, Wooseong [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Nephrol Div,Dept Med, Seoul, South Korea
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P336
引用
收藏
页码：480 / 480
页数：1
相关论文
共 50 条
  • [21] Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation
    Jain, A
    Vekatramanan, R
    Eghtesad, B
    Gadomski, M
    Mohanka, R
    Marcos, A
    Fung, J
    TRANSPLANTATION, 2005, 80 (06) : 859 - 864
  • [22] Long-term Outcomes of Early Steroid Withdrawal (SW) After Kidney Transplant
    Vock, D.
    Matas, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 586 - 586
  • [23] Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus
    Hricik, Donald E.
    Augustine, Joshua J.
    Knauss, Thomas C.
    Bodziak, Kenneth A.
    Aeder, Mark
    Siegel, Christopher
    Schulak, James A.
    TRANSPLANTATION, 2007, 83 (03) : 277 - 281
  • [24] LONG-TERM EFFECTS OF STEROID WITHDRAWAL IN KIDNEY-TRANSPLANTATION
    OFFERMANN, G
    SCHWARZ, A
    KRAUSE, PH
    TRANSPLANT INTERNATIONAL, 1993, 6 (05) : 290 - 292
  • [25] Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C
    Wiesner, RH
    Shorr, JS
    Steffen, BJ
    Chu, AH
    Gordon, RD
    Lake, JR
    LIVER TRANSPLANTATION, 2005, 11 (07) : 750 - 759
  • [26] LONG-TERM OUTCOMES OF MULTITARGET THERAPY OF MYCOPHENOLATE MOFETIL AND TACROLIMUS IN LUPUS NEPHRITIS: A SINGLE CENTER RETROSPECTIVE ANALYSIS
    Imai, Y.
    Ikeuchi, H.
    Suwa, J.
    Ohishi, Y.
    Watanabe, M.
    Nakasatomi, M.
    Hamatani, H.
    Sakairi, T.
    Kaneko, Y.
    Hiromura, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1350 - 1350
  • [27] Recipient age and mycophenolate mofetil as the main determinants of outcome after steroid withdrawal:: Analysis of long-term follow-up in renal transplantation
    Laouad, I
    Halimi, JM
    Büchler, M
    Al-Najjar, A
    Chatelet, V
    Nivet, H
    Lebranchu, Y
    TRANSPLANTATION, 2005, 80 (06) : 872 - 874
  • [28] LONG-TERM OUTCOME OF A RANDOMIZED CONTROLLED TRIAL COMPARING TACROLIMUS WITH MYCOPHENOLATE MOFETIL AS INDUCTION THERAPY OF SEVERE LUPUS NEPHRITIS
    Mok, C. C.
    Ho, L. Y.
    To, C. H.
    Ying, K. Y. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 104 - 104
  • [29] Long-term Outcome of a Randomized Controlled Trial Comparing Tacrolimus with Mycophenolate Mofetil as Induction Therapy of Severe Lupus Nephritis
    Mok, Chi Chiu
    Ho, Ling Yin
    Ying, Shirley
    Ng, Woon Leung
    Leung, Man Chi
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [30] Steroid-Free, Calcineurin Inhibitor Minimizing Regimen with Long-Term Mycophenolate Mofetil Monotherapy for HLA Identical Living Donor Kidney Transplantation: Long-Term Outcomes.
    Shields, A. R.
    Alloway, R. R.
    Govil, A.
    Cardi, M.
    Mogilishetty, G.
    Safdar, S.
    Tevar, A.
    Tipton, S.
    Woodle, E. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 408 - 408
12345